{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:03:12Z","timestamp":1760781792725,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jsbmb.2014.12.009","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T00:09:20Z","timestamp":1419293360000},"page":"111-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Detection and functional portrayal of a novel class of dihydrotestosterone derived selective progesterone receptor modulators (SPRM)"],"prefix":"10.1016","volume":"147","author":[{"given":"Thomas","family":"Andrieu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orlando","family":"Mani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reto","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Guettinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raschid","family":"Setoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla Y.","family":"Uh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix J.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte M.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2014.12.009_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.steroids.2003.08.007","article-title":"Progesterone antagonists and progesterone receptor modulators: an overview","volume":"68","author":"Spitz","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0010","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.2781282","article-title":"Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor","volume":"245","author":"Baulieu","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0022-4731(85)90401-7","article-title":"RU 38486: a potent antiglucocorticoid in vitro and in vivo","volume":"23","author":"Gagne","year":"1985","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/phar.1202","article-title":"Mifepristone for management of Cushing\u2019s syndrome","volume":"33","author":"Morgan","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-07-0458","article-title":"Mifepristone (RU 486) in Cushing\u2019s syndrome","volume":"157","author":"Johanssen","year":"2007","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/07357900601062339","article-title":"Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma","volume":"24","author":"Grunberg","year":"2006","journal-title":"Cancer Invest."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.contraception.2006.03.016","article-title":"Mifepristone and misoprostol sequential regimen side effects, complications and safety","volume":"74","author":"Sitruk-Ware","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.steroids.2008.03.005","article-title":"A new generation of progesterone receptor modulators","volume":"73","author":"Winneker","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.steroids.2013.04.003","article-title":"Synthesis and antiprogestational properties of novel 17-fluorinated steroids","volume":"78","author":"Nickisch","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0050","doi-asserted-by":"crossref","first-page":"26164","DOI":"10.1074\/jbc.M004571200","article-title":"Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations","volume":"275","author":"Matias","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2003.11.007","article-title":"Co-evolution of steroidogenic and steroid-inactivating enzymes and adrenal and sex steroid receptors","volume":"215","author":"Baker","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2010.10.017","article-title":"Origin and evolution of the ligand-binding ability of nuclear receptors","volume":"334","author":"Markov","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0960-0760(94)90257-7","article-title":"Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor","volume":"48","author":"Teutsch","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0070","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.bcp.2011.08.020","article-title":"A novel steroidal antiandrogen targeting wild type and mutant androgen receptors","volume":"82","author":"Andrieu","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0960-0760(91)90192-8","article-title":"Progestin receptors: isoforms and antihormone action","volume":"40","author":"Gronemeyer","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0080","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/hmg\/2.11.1809","article-title":"A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: the mutated receptor fails to transactivate but binds to DNA in vitro","volume":"2","author":"Adeyemo","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/endo.140.2.6480","article-title":"Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta","volume":"140","author":"Sun","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1196\/annals.1321.008","article-title":"The origin and functions of multiple human glucocorticoid receptor isoforms","volume":"1024","author":"Lu","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0095","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","article-title":"Mechanistic aspects of mineralocorticoid receptor activation","volume":"57","author":"Hellal-Levy","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0100","first-page":"4470","article-title":"Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D","volume":"51","author":"Di Lorenzo","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/bc034169o","article-title":"A novel high-affinity, fluorescent progesterone receptor antagonist. Synthesis and in vitro studies","volume":"15","author":"Hodl","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0110","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1210\/en.2010-0525","article-title":"Regulation of placental growth by aldosterone and cortisol","volume":"152","author":"Gennari-Moser","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0120","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/30775","article-title":"Atomic structure of progesterone complexed with its receptor","volume":"393","author":"Williams","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.steroids.2010.10.008","article-title":"3D models of lamprey progesterone receptor complexed with progesterone, 7alpha-hydroxy-progesterone and 15alpha-hydroxy-progesterone","volume":"76","author":"Baker","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0130","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1073\/pnas.081565498","article-title":"Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone","volume":"98","author":"Sack","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0135","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1158\/1078-0432.CCR-12-3327","article-title":"Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer","volume":"19","author":"Gucalp","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2008.11.015","article-title":"Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system","volume":"113","author":"Afhuppe","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0145","first-page":"1525","article-title":"Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen","volume":"45","author":"Reddel","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0150","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1210\/endo.132.6.8504763","article-title":"Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells","volume":"132","author":"Jeng","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0155","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1164\/ajrccm.160.6.9708113","article-title":"Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock","volume":"160","author":"Joly","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0160","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1087057108322155","article-title":"Compound profiling using a panel of steroid hormone receptor cell-based assays","volume":"13","author":"Wilkinson","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0165","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-61-3-536","article-title":"Successful treatment of Cushing\u2019s syndrome with the glucocorticoid antagonist RU 486","volume":"61","author":"Nieman","year":"1985","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jsbmb.2007.10.014","article-title":"Antiproliferative actions of the synthetic androgen mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors","volume":"110","author":"Cops","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0175","first-page":"215","article-title":"Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays","volume":"19","author":"Markiewicz","year":"1997","journal-title":"Meth. Find Exp. Clin. Pharmacol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0960-0760(00)00093-5","article-title":"Influence of the substitution of 11-methylene delta(15), and\/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals","volume":"74","author":"Deckers","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0083-6729(04)68002-2","article-title":"Structure and function of the glucocorticoid receptor ligand binding domain","volume":"68","author":"Bledsoe","year":"2004","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0092-8674(02)00817-6","article-title":"Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition","volume":"110","author":"Bledsoe","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0195","doi-asserted-by":"crossref","first-page":"31283","DOI":"10.1074\/jbc.M504098200","article-title":"A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor","volume":"280","author":"Bledsoe","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.steroids.2012.12.011","article-title":"What are the physiological estrogens?","volume":"78","author":"Baker","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2013.07.009","article-title":"Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors","volume":"137","author":"Baker","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/mol.108.054312","article-title":"Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins","volume":"75","author":"Petit-Topin","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0215","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/me.2006-0524","article-title":"A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator","volume":"21","author":"Madauss","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0220","doi-asserted-by":"crossref","first-page":"19572","DOI":"10.1074\/jbc.M109.007872","article-title":"The X-ray structure of RU486 bound to the progesterone receptor in a destabilized agonistic conformation","volume":"284","author":"Raaijmakers","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/me.2003-0189","article-title":"Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor","volume":"18","author":"Song","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/138620711795222446","article-title":"Two panels of steroid receptor luciferase reporter cell lines for compound profiling","volume":"14","author":"Sedlak","year":"2011","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0235","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1210\/jcem-66-2-290","article-title":"The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man","volume":"66","author":"Laue","year":"1988","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2407-11-207","article-title":"Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression","volume":"11","author":"Tieszen","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/iub.150","article-title":"Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact","volume":"61","author":"Papadopoulou","year":"2009","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.molonc.2010.01.004","article-title":"Testosterone membrane-initiated action in breast cancer cells: interaction with the androgen signaling pathway and EPOR","volume":"4","author":"Pelekanou","year":"2010","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0255","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1096\/fj.02-0131fje","article-title":"The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton","volume":"16","author":"Kampa","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0260","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.22317","article-title":"5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production","volume":"120","author":"Suzuki","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0265","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0039-128X(00)00195-1","article-title":"Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer","volume":"65","author":"Klijn","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0270","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/endo-118-4-1312","article-title":"Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486","volume":"118","author":"Tseng","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2014.12.009_bib0275","first-page":"209","article-title":"Effects of androgens on aromatase activity and 11C-vorozole binding in granulosa cells in vitro","volume":"82","author":"Kirilovas","year":"2003","journal-title":"Acta Obstet. Gynecol. Scand."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007601400315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096007601400315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:46:55Z","timestamp":1760744815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096007601400315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":55,"alternative-id":["S096007601400315X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.12.009","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection and functional portrayal of a novel class of dihydrotestosterone derived selective progesterone receptor modulators (SPRM)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}